Ellevest Inc’s Fortress Biotech FBIO Stock Holding History

Ellevest Inc’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3	Closed	–	–	1487
2021 Q3	$0	Sell	3 -5	-63%	-$244	﹤0.01%	1459
2021 Q2	$0	Buy	8 +5	+167%	+$302	﹤0.01%	1308
2021 Q1	$0	Hold	3	–	–	﹤0.01%	1282
2020 Q4	$0	Buy	+3	New	+$130	﹤0.01%	1237

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ellevest Inc's FBIO Position: Q4 2021 in Review

Ellevest Inc sold out of Fortress Biotech (FBIO) in Q4 2021, closing a stake of 3 shares.

Ellevest Inc first reported a position in FBIO in Q4 2020 and held it in 4 quarters. The position peaked at $0 in Q3 2021. 82 funds tracked by Wall St. Rank hold FBIO as of Q4 2021.

Ellevest Inc reported no remaining Fortress Biotech position as of Q4 2021 after selling out during the quarter.
Ellevest Inc sold 3 Fortress Biotech shares in Q4 2021.
Ellevest Inc first reported a position in Fortress Biotech in Q4 2020 and held it in 4 quarters.
Ellevest Inc's Fortress Biotech position peaked at $0 in Q3 2021.
82 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.